首页> 美国卫生研究院文献>Nucleic Acids Research >USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1
【2h】

USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1

机译:USP9X通过真核翻译起始因子4A1的去泛素化控制翻译效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Controlling translation initiation is an efficient way to regulate gene expression at the post-transcriptional level. However, current knowledge regarding regulatory proteins and their modes of controlling translation initiation is still limited. In this study, we employed tandem affinity purification and mass spectrometry to screen for unknown proteins associated with the translation initiation machinery. Ubiquitin specific peptidase 9, X-linked (USP9X), was identified as a novel binding partner, that interacts with the eukaryotic translation initiation factor 4B (eIF4B) in a mRNA-independent manner. USP9X-deficient cells presented significantly impaired nascent protein synthesis, cap-dependent translation initiation and cellular proliferation. USP9X can selectively alter the translation of pro-oncogenic mRNAs, such as c-Myc and XIAP. Moreover, we found that eIF4A1, which is primarily ubiquitinated at Lys-369, is the substrate of USP9X. USP9X dysfunction increases the ubiquitination of eIF4A1 and enhances its degradation. Our results provide evidence that USP9X is a novel regulator of the translation initiation process via deubiquitination of eIF4A1, which offers new insight in understanding the pivotal role of USP9X in human malignancies and neurodevelopmental disorders.
机译:控制翻译起始是在转录后水平上调节基因表达的有效方法。然而,关于调节蛋白及其控制翻译起始的模式的当前知识仍然是有限的。在这项研究中,我们采用串联亲和纯化和质谱技术来筛选与翻译起始机制相关的未知蛋白质。泛素特异性肽酶9,X连锁(USP9X)被确定为新型的结合伴侣,它以不依赖mRNA的方式与真核翻译起始因子4B(eIF4B)相互作用。 USP9X缺陷细胞呈现出严重损害新生蛋白质合成,帽依赖性翻译起始和细胞增殖的功能。 USP9X可以选择性地改变促癌性mRNA(例如c-Myc和XIAP)的翻译。此外,我们发现主要在Lys-369处泛素化的eIF4A1是USP9X的底物。 USP9X功能障碍会增加eIF4A1的泛素化并增强其降解。我们的结果提供了证据,表明USP9X是通过eIF4A1的去泛素化作用来翻译启动过程的新型调节剂,为了解USP9X在人类恶性肿瘤和神经发育疾病中的关键作用提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号